Splicing intervention for Duchenne muscular dystrophy

Graham Mcclorey, Susan Fletcher, Steve Wilton

Research output: Contribution to journalArticlepeer-review

22 Citations (Scopus)


The manipulation of pre-mRNA to alter gene transcript splicing patterns offers considerable potential for many genetic disorders. In particular, the targeted removal of one or more exons from a gene transcript can skip over, or compensate for, disease-causing mutations. Duchenne muscular dystrophy (DMD), the most common and severe form of muscular dystrophy, is one such disorder that could benefit from this strategy. Splicing modulation can convert a DMD phenotype into the less severe allelic Becker-like phenotype. Recent studies using antisense oligonucleotide-targeted exon skipping to induce near normal dystrophin in vivo in animal models, and in vitro in DMD cell lines, highlight the promise of this approach. On the basis of these successes, human clinical trials could be realized in the near future.
Original languageEnglish
Pages (from-to)529-534
JournalCurrent Opinion in Pharmacology
Issue number5
Publication statusPublished - 2005


Dive into the research topics of 'Splicing intervention for Duchenne muscular dystrophy'. Together they form a unique fingerprint.

Cite this